Offer - Urjas Oil for just ₹ 1
Glimiprime Mp is a prescription medicine that is available as a Tablet. Diabetes are some of its major therapeutic uses. Glimiprime Mp also has some secondary and off-label uses. These are listed below.
Medical history of the patient along with age and gender determines the dosage of Glimiprime Mp. Individual symptoms and route of administration also determines the right dosage. For detailed information on this, read through the dosage section.
Glimiprime Mp also has some side effects, the most common being Nausea or vomiting, Diarrhoea, Headache. Besides the aforementioned side effects, there are other adverse effects of Glimiprime Mp as well, which are listed below. Normally, these side effects of Glimiprime Mp are not long lasting and go away when the treatment is finished. If, however, they worsen or do not go away, please speak with your physician.
Glimiprime Mp's effect during pregnancy is Unknown and Safe while nursing. In addition, Glimiprime Mp's effects on the liver, heart and kidney are discussed below in the Glimiprime Mp related warnings section.
Glimiprime Mp can cause adverse effects in certain medical conditions. It is strongly recommended to avoid Glimiprime Mp in conditions like Liver Disease, Kidney Disease.
Additionally, Glimiprime Mp may also adversely react with other medicines. Refer to the list below for further details.
In addition to the above precautions for Glimiprime Mp, it is important to know that it is not safe while driving, and is not habit-forming.
Glimiprime Mp is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
Is the use of Glimiprime Mp safe for pregnant women?
No research has been done to ascertain the safety of Glimiprime Mp in pregnant women. If you are pregnant, it is best to ask a doctor to know if you can take it.
Is the use of Glimiprime Mp safe during breastfeeding?
Glimiprime Mp does not show any side effects in breastfeeding women.
What is the effect of Glimiprime Mp on the Kidneys?
There may be some adverse effects on kidney after taking Glimiprime Mp. If you observe any such side effects, stop taking this drug. Consume this medicine again only if your doctor advises you to do so.
What is the effect of Glimiprime Mp on the Liver?
You may experience side effects on your liver after taking Glimiprime Mp. If this happens, then discontinue its use. Consult your medical practitioner, do as he/she suggests.
What is the effect of Glimiprime Mp on the Heart?
Glimiprime Mp has very mild side effects on the heart.
Glimiprime Mp should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
If you are suffering from any of the following diseases, you should not take Glimiprime Mp unless your doctor advises you to do so -
Is this Glimiprime Mp habit forming or addictive?
No, there is no any evidence that Glimiprime Mp is addictive.
Is it safe to drive or operate heavy machinery when consuming?
After taking Glimiprime Mp you may feel sleepy. So it is not advised to perform these activities.
Is it safe?
Yes, but consume Glimiprime Mp only on doctor's advice.
Is it able to treat mental disorders?
Glimiprime Mp is unable to treat or cure mental disorders.
Interaction between Food and Glimiprime Mp
There isn't any research available on the side effects of taking Glimiprime Mp with food.
Interaction between Alcohol and Glimiprime Mp
Information about the interaction of Glimiprime Mp and alcohol is not currently available because this topic has not been researched yet.
This medicine data has been created by -
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Amaryl (glimepiride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 272
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1156-1158
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Glucophage® (metformin hydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 275-276
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 825-826
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Actos (pioglitazone hydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 276-277
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1032-1033